Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2025 Earnings Call Transcript

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2025 Earnings Call Transcript March 26, 2026

Acumen Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.41, expectations were $-0.5.

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Acumen Pharma Fourth Quarter 2025 Conference Call and Webcast. [Operator Instructions] Please be advised that today’s conference is being recorded. I would like now to turn the conference over to Alex Braun, Head of Investor...